Asan Medical Center: Carcinoma, Hepatocellular trials

The registry lists 18 Carcinoma, Hepatocellular studies with Asan Medical Center as lead sponsor. 6 are open to participants now and 1 have results posted.

Phase 2 9Phase 3 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE)Not yet recruitingNCT07495579Phase 2
• Immunogenomic Dynamics and Biomarkers in Patients With Hepatocellular Carcinoma Receiving ImmunotherapyRecruitingNCT07186010
• A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular CarcinomaRecruitingNCT07010497Phase 2
• Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCCRecruitingNCT06819566Phase 2
• Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative TreatmentRecruitingNCT06537193Not applicable
• Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular InvasionRecruitingNCT05992220Phase 2
• Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk PatientsCompletedNCT01446666Results posted
• ThinkRadial: A Prospective Study of Transradial deTACE in HCC PatientsCompletedNCT07160374
• Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High RiskActive, not recruitingNCT06312826Not applicable
• Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver TransplantCompletedNCT06233708
• Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular CarcinomaActive, not recruitingNCT06138769Phase 2
• Combination of Regorafenib and Nivolumab in Unresectable Hepatocellular CarcinomaCompletedNCT04310709Phase 2
• Needle Guiding Robot for Radiofrequency Ablation: Safety and Efficacy Study on Hepatocellular Carcinoma PatientsStatus unknownNCT03005756Not applicable
• The Effect of Telephone Counseling on the Compliance and Satisfaction for Advanced HCC Patients Receiving SorafenibStatus unknownNCT02564666Not applicable
• Quality of Life in Patients With Hepatocellular CarcinomaStatus unknownNCT02420678
• Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study)Status unknownNCT02311205Phase 2
• Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular InvasionCompletedNCT01901692Phase 2/3
• Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC)WithdrawnNCT01432314Phase 2